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Abstract
Subepithelial deposits are observed in rare adult IgA nephropathy (IgAN) cases and are a
key diagnostic finding in IgA-dominant infection-related glomerulonephritis (IgA-IRGN).
Sometimes, it is difficult to distinguish IgA-IRGN from IgAN without a precise clinical history.
We hypothesized that some IgA-IRGN cases might be diagnosed as IgAN with subepithelial
deposits (IgAN-SD) and aimed to clarify the significance of subepithelial deposits in patients
diagnosed with IgAN. We examined 464 patients diagnosed with IgAN at Nagasaki Univer-
sity Hospital and affiliated hospitals between 1996 and 2013. The differences in clinico-
pathological findings between IgAN-SD and IgAN with no subepithelial deposits (IgAN-
NSD) were investigated. In addition to clinical data and typical IgAN pathological features,
we analyzed complement levels, immunoglobulin localization, light chain staining patterns,
and intramembranous deposits. There were 214 men and 250 women with a mean age of
38.8 ± 18.3 years. Subepithelial deposition was observed in 51 patients (11%). Compared
to patients with IgAN-NSD, those with IgAN-SD had significantly lower mean serum protein
(6.4 g/dL vs. 6.7 g/dL; p = 0.02), albumin (3.7 g/dL vs. 3.9 g/dL; p = 0.02), and complement
(C3) (94 mg/dL vs. 103 mg/dL; p = 0.02) levels. Diffuse mesangial hypercellularity (M) (65%
vs. 45%; p<0.01), endocapillary hypercellularity: (E) (43% vs. 28%; p = 0.03), and IgA stain-
ing in the glomerular capillary wall (22% vs. 8%; p<0.01) were more common in patients
with IgAN-SD. The incidence of light chain lambda predominance was lower in patients with
IgAN-SD (47% vs. 63%; p = 0.03). Hump-shaped subepithelial deposits and intramembra-
nous deposits were observed in nine and 17 patients with IgAN-SD, respectively. Patients
with IgAN-SD tended to have the characteristics of IgA-IRGN rather than IgAN-NSD. Since
the therapeutic strategies for IgA-IRGN differ from those for IgAN, we should review the clin-
ical history and pay careful attention to the clinical course in cases with atypical findings,
such as subepithelial deposits.
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Introduction
IgA nephropathy (IgAN) is defined by the presence of dominant or co-dominant mesangial
IgA immune deposits, often accompanied by C3 deposits and abnormal findings on urinalysis,
and the exclusion of other etiologies for IgA deposition [1,2]. The light microscopic features of
IgAN are diverse; mesangial lesions vary from minimally changed to diffusely proliferated,
and may have sclerosis and/or crescents [3]. Although electron dense deposits (EDDs) in the
mesangial area are one of the typical electron microscopic findings of IgAN, some cases show
additional deposits involving the glomerular capillary wall [4,5]. The clinicopathological fea-
tures of IgAN differ among patients; hence, several factors are thought to be associated with
the onset and progression of IgAN [2,6,7].
About 30 years ago, a few studies investigated the location of EDDs in IgAN and speculated
that capillary wall deposits, including subepithelial deposits, were associated with its severity
[4,5]. Several cases and case-series of IgA-dominant infection-related glomerulonephritis
(IgA-IRGN), such as methicillin resistant staphylococcus aureus (MRSA)-related glomerulo-
nephritis, have been reported since 1995 [8–11]. The clinical features of IgA-IRGN resemble
those of post-streptococcal infection-related glomerulonephritis in terms of endocapillary
hypercellularity, hypocomplementemia, and hump-shaped subepithelial deposits [8,11]. Dur-
ing the course of healing, the subepithelial deposits shrink and move to the intramembranous
area [11]. Therefore, past studies have noted a difficulty in distinguishing IgA-IRGN from
IgAN without a precise clinical history [10–13].
Although previous studies had shown that the subepithelial deposits in IgAN were associ-
ated with the severity of urinary abnormality, especially proteinuria [4], the clinicopathological
significance of subepithelial deposits remains unknown. Some reports have proposed that sev-
eral findings are useful for distinguishing IgA-IRGN from IgAN, such as subepithelial deposits,
hypocomplementemia, and the absence of lambda predominance [11,12]. However, few stud-
ies have validated these findings in patients diagnosed with IgAN.
In this study, we investigated IgAN patients while focusing on subepithelial deposit-positive
patients diagnosed as having “IgA nephropathy” and hypothesized that some patients with
IgAN with subepithelial deposits (IgAN-SD) might have been diagnosed with IgA-IRGN
because of the lack of appropriate clinical histories. To elucidate the clinicopathological char-
acteristics of IgAN-SD, we compared patients with IgAN-SD and those with IgAN with no
subepithelial deposits (IgAN-NSD).
Materials and methods
This was a cross sectional study. We examined patients diagnosed with IgAN at Nagasaki Uni-
versity Hospitals and its affiliated hospitals between 1996 and 2013. The exclusion criteria for
this study were age<15 years at renal biopsy; incomplete immunofluorescence data; and the
presence of secondary causes of mesangial IgA deposits, such as IgA vasculitis, lupus erythe-
matosus, IgA-IRGN, and IgAN complicated with membranous nephropathy. Patients in
whom the glomerulus could not be observed by electron microscopy were also excluded.
We collected the demographic data of patients, including age, sex, blood examinations, and
urinary tests, from their renal biopsy request forms. We also collected pathological data,
including light microscopy, immunofluorescence staining, and electron microscopy data. As
the standard of hypocomplementemia; we adopted the following standard, CH50; <30 U/mL,
C3;<73 mg/dL, and C4<11 mg/dL.
Light microscopic analysis was performed based on the 2016 revision of the Oxford classifi-
cation [14]. In brief, the following were assessed: mesangial cellularity score,<0.5 (M0) or>0.5
(M1); endocapillary hypercellularity, absent (E0) or present (E1); segmental glomerulosclerosis,
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absent (S0) or present (S1); interstitial fibrosis/tubular atrophy,�25% (T0), 26–50% (T1), or
>50% (T2); and cellular/fibrocellular crescents, absent (C0), present in at least 1 glomerulus
(C1), or present in>25% of glomeruli (C2).
The immunofluorescence studies were performed using direct fluorescent antibodies to
human IgG, IgA, IgM, C3, C1q, fibrinogen, kappa, and lambda. The amount and extent of fluo-
rescence were graded from 0 to 4+, and positive cases were defined as those�1+. The light chain
staining pattern was classified into two groups: lambda-dominant group and non-lambda-domi-
nant group, which included kappa-dominant cases and lambda and kappa-equivalent cases [15].
Electron microscopic findings were evaluated for the presence of subepithelial and endothe-
lial deposits and mesangial interposition. In IgAN-SD, the characteristics of EDDs were also
evaluated; for example, hump-shape and the presence or absence of accompanying intramem-
branous deposits.
For comparing the characteristics of IgA-IRGN and IgAN-SD, we also collected the infor-
mation of cases diagnosed as IgA-IRGN in our hospital.
Clinicopathological findings were compared between patients with IgAN-SD and those
with IgAN-NSD. Statistical analyses were performed using the Wilcoxon rank-sum test for
continuous variables and the chi-squared test for categorical variables using JMP 13 software
(SAS Institute Inc., Cary, NC). The missing data were removed from the analyses and only the
remaining data were used.
This study was approved by the ethics committee of Nagasaki University Hospital (Naga-
saki, Japan) (18082002). Although all patients in this study were informed, since this was a
cross-sectional study, the ethics committee waived the need for informed consent.
Results
The number of eligible patients was 464. There were 214 men and 250 women with an overall
mean age of 38 ± 18 years. The demographic data and pathological findings of all patients are
shown in Table 1. There were 51 patients with subepithelial deposits (IgAN-SD group) and
413 without (IgAN-NSD group) (Table 1).
Compared to patients with IgAN-NSD, those with IgAN-SD showed higher levels of pro-
teinuria, lower proteinemia, and lower serum C3. The mesangial cellularity score (M), inci-
dence of endocapillary hypercellularity (E), and IgA staining in the glomerular capillary walls
were higher in the IgAN-SD group. The representative figures of IgA and C3 showing mesan-
gial and/or capillary deposition are shown in Fig 1.
The light chain staining patterns were lambda-dominant in 284 patients, lambda and
kappa-equivalent in 159, and kappa-dominant in 21. Therefore, there were 284 patients with
lambda-dominance and 180 without. The incidence of light chain lambda-predominance was
lower in patients with IgAN-SD. Subendothelial deposits and mesangial interposition tended
to be seen in patients with IgAN-SD (Table 1). Hump-shaped subepithelial deposits were
observed in nine patients (18%) and intramembranous deposits in 17 (33%).
Among the patients with hump-shaped subepithelial deposits, four presented with lower
serum C3 levels, three showed endocapillary hypercellularity, and the intensity of immunoflu-
orescence of C3 was codominant or more dominant than that of IgA in six patients. Case 4, 5,
and 8 had hypercellularity and neutrophils were observed in these three cases in hypercellular-
ity lesions, however, the numbers of neutrophils were quite a few.
The period of this study was about 18 years; we divided the period into the earlier period
(1996–2004) and the later period (2005–2013) and compared the prevalence of IgAN-SD
between the two periods. The proportion of IgAN-SD was 13.0% in the earlier period and
9.8% in the later period, with no significant difference (p = 0.29)
Subepithelial deposits in IgA nephropathy
PLOS ONE | https://doi.org/10.1371/journal.pone.0211812 February 20, 2019 3 / 10
Table 1. The demographic and clinicopathological characteristics of the patients and the differences in clinicopathological and demographic characteristics
between IgAN-SD and IgAN-NSD patients.
Total IgAN-SD IgAN-NSD p-value
Numbers 464 51 413
Age (years) 38.8 ± 18.3 39.3 ± 19.7 38.8 ± 18.2 0.99
Sex M, 214; F, 250 M, 25; F, 26 M, 189; F, 224 0.66
Height (cm) 162 ± 9 161 ± 10 162 ± 9 0.33
Body weight (kg) 59.1 ± 12.2 57.7 ± 11.2 59.3 ± 12.4 0.46
sBP (mmHg) 125 ± 19 125 ± 18 125 ± 19 0.61
dBP (mmHg) 73 ± 13 74 ± 12 73 ± 13 0.53
Hb (g/dL) 13.0 ± 1.9 12.9 ± 1.8 13.0 ± 1.9 0.71
WBC (/μL) 6506 ± 1846 6669 ± 1753 6486 ± 1858 0.35
CRP (mg/dL) 0.46 ± 1.47 0.53 ± 1.32 0.45 ± 1.49 0.71
TP (g/dL) 6.7 ± 0.8 6.4 ± 0.9 6.7 ± 0.8 0.02
Alb (g/dL) 3.9 ± 0.7 3.7 ± 0.8 3.9 ± 0.7 0.02
T-Chol (mg/dL) 201 ± 53 204 ± 63 200 ± 51 0.73
TG (mg/dL) 131 ± 109 115 ± 82 134 ± 112 0.42
BUN (mg/dL) 16.1 ± 8.6 16.6 ± 11.4 16.1 ± 8.2 0.92
Cr (mg/dL) 0.98 ± 0.83 0.99 ± 0.81 0.98 ± 0.83 0.99
UA (mg/dL) 5.7 ± 1.8 5.8 ± 1.6 5.7 ± 1.8 0.46
IgA (mg/dL) 351 ± 152 343 ± 152 352 ± 152 0.70
CH50 (U/mL) 41 ± 9 39 ± 10 42 ± 9 0.14
C3 (mg/dL) 102 ± 23 94 ± 26 103 ± 23 0.02
C4 (mg/dL) 24 ± 8 24 ± 7 25 ± 9 0.89
U-Pro (g/gCr) 1.50 ± 2.49 2.02 ± 1.99 1.42 ± 2.55 0.01
U-abnormality (months) 56 ± 90 63 ± 108 56 ± 87 0.57
Hypocomplementemia 11% 12% 10% 0.72
Nephrotic syndrome 5.2% 7.8% 4.8% 0.36
Hematuria Number (%) Number (%) Number (%)
0–4/HPF 83 (18%) 3 (6%) 80 (19%)
5–9/HPF 53 (11%) 5 (10%) 48 (12%)
10–19/HPF 72 (16%) 9 (18%) 63 (15%)
20–49/HPF 113 (24%) 15 (29%) 98 (24%)
50–99/HPF 57 (12%) 5 (10%) 52 (13%)
>100/HPF 80 (17%) 14 (27%) 66 (16%)
History of macrohematuria 86 (19%) 12 (24%) 74 (18%) 0.33
Oxford Classification Number (%) Number (%) Number (%)
M0 245 (53%) 18 (35%) 227 (55%)
M1 219 (47%) 33 (65%) 186 (45%) 0.008
E0 325 (70%) 29 (57%) 296 (72%)
E1 139 (30%) 22 (43%) 117 (28%) 0.03
S0 292 (63%) 34 (67%) 258 (63%)
S1 172 (37%) 17 (33%) 155 (37%) 0.56
T0 323 (70%) 35 (69%) 288 (70%)
T1 127 (27%) 14 (27%) 113 (27%)
T2 14 (3%) 2 (4%) 12 (3%) 0.92
C0 272 (59%) 27 (53%) 245 (59%)
C1 154 (33%) 19 (37%) 135 (33%)
C2 38 (8%) 5 (10%) 33 (8%) 0.68
(Continued)
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Table 1. (Continued)
Total IgAN-SD IgAN-NSD p-value
Light Microscopy Mean ± SD Mean ± SD Mean ± SD
Total glomeruli 20.2 ± 12.3 18.8 ± 9.9 20.4 ± 12.6 0.26
Crescent (%) 8.7 ± 15.2 7.0 ± 10.0 8.9 ± 15.7 0.63
Global Sclerosis (%) 14.3 ± 18.5 13.7 ± 19.1 14.6 ± 18.6 0.50
Immunofluorescence Number (%) Number (%) Number (%)
IgG-M 74 (16%) 10 (20%) 64 (16%) 0.38
IgG-GBM 7 (2%) 2 (4%) 5 (1%) 0.13
IgA-M 464 (100%) 51 (100%) 413 (100%)
IgA-GBM 45 (10%) 11 (22%) 34 (8%) 0.002
IgM-M 325 (70%) 36 (70%) 289 (70%) 0.93
IgM-GBM 17 (4%) 4 (8%) 13 (3%) 0.13
C3-M 423 (91%) 47 (92%) 376 (91%) 0.83
C3-GBM 29 (6%) 10 (20%) 19 (5%) <0.001
C1q-M 40 (9%) 4 (8%) 36 (9%) 0.83
C1q-GBM 3 (1%) 0 (0%) 3 (1%) 0.54
lambda-dominant 284 (61%) 24 (47%) 260 (63%) 0.03
Electron microscopy Number (%) Number (%) Number (%)
Subendothelial deposits 58 (13%) 11 (22%) 47 (11%) 0.045
Mesangial interposition 214 (47%) 34 (67%) 180 (44%) 0.003
SD: standard deviation, IgAN-SD: IgA nephropathy with subepithelial deposits, IgAN-NSD: IgA nephropathy with subepithelial deposits, Ig: immunoglobulin, sBP:
systolic blood pressure, dBP: diastolic blood pressure, Hb: hemoglobin, WBC: white blood cell, CRP: C reactive protein, TP: total protein, Alb: albumin, T-Chol: total
cholesterol, TG: triglyceride, BUN: blood urea nitrogen, Cr: creatinine, UA: uric acid, U-abnormality: duration of urinary-abnormality, HPF: high power field, GBM:
glomerular basement membrane.
https://doi.org/10.1371/journal.pone.0211812.t001
Fig 1. Representative immunofluorescence patterns of IgA and C3. (A) IgA deposition and (B) C3 deposition in
mesangial areas in a typical IgA nephropathy case. (C) IgA deposition and (D) C3 deposition in both mesangial and
capillary areas in an atypical IgA nephropathy case. All magnifications of photos are x400.
https://doi.org/10.1371/journal.pone.0211812.g001
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The clinicopathological features of patients with hump-like subepithelial deposits and diag-
nosed IgA-IRGN in our hospital are summarized in Table 2 and the electron microscopic
photo of a representative case is shown in Fig 2.
The diagnosed IgA-IRGN cases were all in men and those who tended to have diabetes;
moreover, infiltrating neutrophils were observed in cases with endocapillary hypercellularity
lesions. All cases had histories of infection, which were associated with MRSA or methicillin-
susceptible Staphylococcus aureus before renal biopsy. However, there were only few cases of
IgA-IRGN and statistical analyses were not performed.
Discussion
In the present study, we investigated 464 cases of IgAN and 51 of IgAN-SD. Our results
showed that subepithelial deposits may be associated with lower serum protein levels, lower
serum C3 levels, mesangial proliferation, endocapillary hypercellularity, higher incidence of
IgA staining in the glomerular capillary wall, and absence of lambda-predominance. Among
the patients with IgAN-SD, nine (18%) showed hump-shaped subepithelial deposits.
The clinical significance of subepithelial deposits in IgAN remains unclear; however, previ-
ous studies have shown that the prevalence of subepithelial deposit-positive cases is about 13–
Table 2. Clinical characteristics of IgAN-SD patients with hump-like subepithelial deposits and diagnosed IgA-IRGN cases.





















locat.M E S T C
IgAN-SD with hump-shaped subepithelial deposits
1 18 M (-) (+) 0.8 88 18 1.8 >100 0 0 0 1 1 (-) 3+ 1+ 2+ 1+ No MEpEn
2 22 M (-) (+) 0.7 34 38 0.1 >100 1 0 0 0 0 (-) 1+ - 1+ 1+ No MEp
3 23 M (-) (-) 0.7 112 31 0.2 50–99 1 0 0 0 1 (+) 2+ - 1+ - Yes MEp
4 38 F (-) (-) 1.1 68 24 2.6 20–29 0 1 0 0 1 (+) 1+ - 2+ 1+ Yes MEp
5 39 F (-) (-) 0.7 41 16 1+�1 15–20 1 1 0 0 0 (+) 1+ - 1+ - No MEp
6 51 F (-) (-) 0.5 17 22 -�1 20–29 1 0 0 1 0 (+) 1+ - 1+ - Yes MEp
7 61 M (+) (-) 1.1 NA NA 2.0 >100 1 0 0 1 2 (-) 1+ - 1+ - No MEp
8 75 F (-) (+) 0.6 81 17 8.3 1–4 1 1 0 0 0 (+) 1+ - - - No MEpEn
9 80 M (+) (-) 5.5 95 22 1.9 >100 1 0 0 1 0 (-) 1+ - 1+ - Yes MEp





















locat.M E S T C
Cases diagnosed as IgA-IRGN
1 18 M (-) (+) 0.5 95 22 1.9 >100 1 1 0 0 0 (-) 1+ - - - NA MEpEn
2 48 M (-) (+) 1.4 NA NA 0.08 5–9 0 0 0 2 0 (-) 1+ - 1+ - NA M
3 79 M (-) (+) 3 73 21 1+�1 >100 0 0 0 0 1 (-) 2+ 2+ 1+ 2+ No MEpEn
4 56 M (+) (+) 0.8 134 35 7.2 >100 0 1 0 0 0 (+) 1+ - 1+ - NA M
5 69 M (-) (+) 3.7 124 32 3 >100 1 1 0 1 1 (+) 1+ - 1+ - No M
6 60 M (+) (+) 4.79 115 35 6.4 11–20 0 1 0 0 1 (+) 1+ - 1+ - NA MEpEn
7 78 M (-) (+) 2.94 64 30 10.1 5–9 1 1 0 1 1 (+) 2+ 1+ 3+ 2+ No NA
Age: years, IgAN-SD: IgA nephropathy with subepithelial deposits, M: male, F: female, DM: diabetes mellitus, Pre infect.: histories of infection before biopsy written in
renal biopsy request forms, Cr: serum creatinine (mg/dL), C3: serum C3 (mg/dL), C4: serum C4(mg/dL), U-Pro: protein-to-creatinine ratio (g/gCr), U-RBC: urinary
sediment red blood cells/ high power field, M: Oxford classification M, E: Oxford classification E, S: Oxford classification S, T: Oxford classification T, C: Oxford
classification C, Neu: neutrophil infiltration in capillary, IF IgA: intensity of immune fluorescence of IgA, IF C3: intensity of immune fluorescence of C3, λ-D: Lambda
dominance in immune fluorescence, EDD locat.: Electron dense deposits location, M:mesangium Ep: subepithelial En: Subendothelial, SEnD: subendothelial deposits,
NA: not available
�1 The results of quantitative urinary protein were not available
https://doi.org/10.1371/journal.pone.0211812.t002
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18% [5,13] and that they seemed to be associated with indicators of clinical severity, such as
the extent of proteinuria and renal function [4,5]. Subepithelial deposits tended to be more fre-
quently observed in IgAN patients with mesangial and capillary wall deposits (50%) than in
those with only mesangial deposits (3%) [4]. In this study, the incidence of subepithelial depos-
its was 11%, and patients with IgAN-SD exhibited more severe proteinuria and a higher inci-
dence of capillary wall staining compared to patients with IgAN-NSD. These findings were
consistent with previous reports [4,5]. Patients with IgAN-SD also showed lower serum C3 lev-
els and an absence of lambda-dominance compared with those with IgA-NSD. These findings
were not mentioned in previous studies [4,5] and are also typical features of infection-related
glomerulonephritis, not limited to IgA dominant cases.
No established clinical criteria for the diagnosis of IgA-IRGN have been developed. However,
a previous study used the presence of at least three of the following criteria for diagnosis [16]: (1)
clinical or laboratory evidence of infection preceding or concurrent with onset, (2) reduced serum
complement, (3) endocapillary proliferative and exudative glomerulonephritis, (4) C3-dominant
or co-dominant glomerular immunofluorescence staining, and (5) hump-shaped subepithelial
deposits. Among these criteria, the clinical history of infection should be the most important.
However, the hump-like subepithelial deposits seen in IgAN-SD cases 4 and 5 could be diagnosed
as IgA-IRGN using these criteria despite the absence of a history of infection (Table 2).
The interpretation of infectious clinical history and etiology is sometimes difficult in both
IgAN and IgA-IRGN. MRSA is the most famous etiology for IgA-IRGN, and patients tend to
be elderly and diabetic. However, other pathogens, such as gram-negative rods, are known to
cause IgA-IRGN, and in such cases the patients are not limited to diabetics and the elderly
[17,18]. On the other hand, various infections, such as tonsillitis, exacerbate IgAN and may be
associated with its onset according to the multi-hit theory [19,20]. Although the short latency
period and gross hematuria after infection are specific to IgAN, these features are not observed
in all cases.
Fig 2. Electron microscopic photograph of representative case of hump-shaped subepithelial deposits in
IgAN-SD. Case 7 in Table 2 upper side is shown.
https://doi.org/10.1371/journal.pone.0211812.g002
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According to previous reports, the ultrastructural features of IgA-IRGN resemble those of
poststreptococcal glomerulonephritis. IgA-IRGN has been subclassified into three stages
according to the healing process: acute, subacute, and persistent/resolving [11,21]. In the acute
stage, diffuse endocapillary hypercellularity with prominent neutrophil infiltration and promi-
nent subepithelial humps exists. In the subacute stage, the glomeruli show mesangial prolifera-
tion in addition to segmental endocapillary hypercellularity with few neutrophils and/or
subepithelial humps showing evidence of resorption. Loss of neutrophils, mesangial prolifera-
tion, and resorbed subepithelial and intramembranous deposits characterize the persistent/
resolving stage. Based on these characteristics, IgA-IRGN could be misdiagnosed as IgAN
when in the subacute or persistent/resolving stages [11].
The mechanisms underlying subepithelial deposition are thought to be associated with endoca-
pillary hypercellularity, while proteolytic enzyme-producing infiltrating cells and basement mem-
brane injury result in proteinuria [22,23]. In this study, the incidence of endocapillary
hypercellularity was significantly higher in patients with IgAN-SD. Therefore, subepithelial deposits
could be caused by endocapillary hypercellularity, similarly to infection-related glomerulonephritis.
Previous studies have shown a lambda-dominant mesangial light chain staining pattern in
IgAN [15,24,25], although concomitant IgG or IgM staining in the mesangial area may affect
the interpretation of light chain staining patterns. Conversely, staining for kappa was equal or
stronger in more than two-thirds of patients with IgA-IRGN [11,16]. Although the precise
mechanism remains unclear, a previous report showed that the proportion of circulating IgA-
kappa/IgA-lambda in patients with IgAN was lower than that in healthy controls [26]. In con-
trast, patients with IgA-IRGN may not exhibit the decreased kappa/lambda ratio of IgA and
would thus have different light chain staining patterns. Therefore, light chain staining patterns
could be a candidate tool for distinguishing IgA-IRGN from IgAN.
There are several limitations to this study. First, recent research has shown that immunofluo-
rescence analysis using KM55 monoclonal antibody can clearly distinguish IgAN and IgA vasculi-
tis from other etiologies of IgA deposition [27]. It may be useful to distinguish IgA-IRGN from
IgAN. However, we did not perform immunofluorescence analysis using KM55 in this study
because the available renal tissues were limited among the included patients. We want to elucidate
whether KM 55 positive rate differs between IgAN-SD and IgAN-NSD in a future study. Second,
although the clinical history is critical to renal pathological diagnoses, our diagnoses depended on
renal biopsy request forms, and some cases lacked a precise clinical history, especially with respect
to infection. The history of infection, such as tonsillitis or upper respiratory infections, was written
in the renal biopsy request forms of only 90 cases (19%). However, this reporting would be lower
than the prevalence of the actual history, because some renal biopsy request forms were poorly
described and information bias should have existed. Moreover, the written anti-streptolysin O
information was available in 117cases (25%) of the renal biopsy request forms. Third, this study
was conducted between 1996 and 2013, while Koyama et al. proposed IgA-IRGN in 1995. There-
fore, diagnoses early in the study period were made without specific awareness of IgA -IRGN. As
shown in the results, the proportion of IgAN-SD was higher in the earlier period than those in the
later period; however, there was no significant difference. Fourth, clinical data were lacking in sev-
eral cases. Despite this, the renal biopsy request forms were almost identical during the study
period. Furthermore, the results of blood and urinary examinations may differ among facilities
due to varying equipment and measurement methods.
Conclusions
Obtaining clinical histories is crucial for renal pathological diagnosis and lack thereof may lead
to misdiagnosis or diagnosis of the most probable disease. Therefore, patients with IgA-IRGN
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without a precise infection history may be diagnosed with IgAN. The atypical findings in
IgAN might aid in distinguishing it from IgA-IRGN. When encountering patients with the
unusual pathological findings of IgAN, such as subepithelial deposits, their medical record or
clinical history must be thoroughly reviewed. On the other hand, when encountering the
unusual features of IgAN on blood examinations, light microscopy, and immunofluorescence
studies, electron microscopy analysis should be performed promptly to validate the treatment
policy.
Supporting information
S1 Data. Patients’ data are supplied in a supporting information file.
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